BLKB supporting startups in Basel region Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and…annett03.04.2021
BioVersys receives funding in the fight against tuberculosis The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners.…annett03.01.2021
Biosynex takes up residence in Delémont The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a…annett03.01.2021
Novartis Campus opening further Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus.…annett02.25.2021
docdok.health increases safety of coronavirus vaccinations The Basel-based startup docdok.health has developed an app that aims to increase the safety and…annett02.25.2021
Hemex attracts Swiss investors A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed…martin02.11.2021
Rhizen drug secures approval in the USA The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib.…martin02.10.2021
Novaremed secures US$50 million Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed…martin02.03.2021
Axtria driving growth from Basel The US firm Axtria has established a new office in Basel. The company offers services…martin02.01.2021
Technologiepark Basel celebrates its role as a driver of innovation The Technologiepark Basel will be ten years old in 2021. Over the past decade, it…martin01.28.2021